Capital World Investors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.63B | Buy |
30,075,134
+1,810,554
| +6% | +$341M | 0.67% | 38 |
|
|
2026
Q1 | $5.52B | Buy |
28,264,580
+27,807,540
| +6,084% | +$5.36B | 0.75% | 28 |
|
|
2025
Q4 | $84.1M | Sell |
457,040
-89,770
| -16% | -$15.7M | 0.01% | 371 |
|
|
2025
Q3 | $83.5M | Buy |
546,810
+470,031
| +612% | +$71.1M | 0.01% | 359 |
|
|
2025
Q2 | $10.7M | Buy |
76,779
+2,119
| +3% | +$297K | ﹤0.01% | 499 |
|
|
2025
Q1 | $11M | Buy |
74,660
+3,145
| +4% | +$455K | ﹤0.01% | 484 |
|
|
2024
Q4 | $9.38M | Sell |
71,515
-3,055,826
| -98% | -$428M | ﹤0.01% | 480 |
|
|
2024
Q3 | $487M | Buy |
3,127,341
+1,171
| +0% | +$189K | 0.08% | 195 |
|
|
2024
Q2 | $488M | Sell |
3,126,170
-1,556,668
| -33% | -$234M | 0.08% | 184 |
|
|
2024
Q1 | $635M | Buy |
4,682,838
+14,748
| +0.3% | +$1.95M | 0.11% | 175 |
|
|
2023
Q4 | $629M | Buy |
4,668,090
+209
| +0% | +$27.2K | 0.11% | 171 |
|
|
2023
Q3 | $632M | Buy |
4,667,881
+94,879
| +2% | +$13M | 0.13% | 161 |
|
|
2023
Q2 | $654M | Buy |
4,573,002
+404,889
| +10% | +$59.6M | 0.13% | 167 |
|
|
2023
Q1 | $579M | Buy |
4,168,113
+551,152
| +15% | +$74.2M | 0.12% | 175 |
|
|
2022
Q4 | $490M | Buy |
3,616,961
+1,898,534
| +110% | +$238M | 0.1% | 182 |
|
|
2022
Q3 | $188M | Buy |
1,718,427
+600,091
| +54% | +$76.1M | 0.04% | 274 |
|
|
2022
Q2 | $148M | Sell |
1,118,336
-1,474,906
| -57% | -$194M | 0.03% | 299 |
|
|
2022
Q1 | $344M | Sell |
2,593,242
-4,651
| -0.2% | -$558K | 0.06% | 241 |
|
|
2021
Q4 | $303M | Buy |
2,597,893
+8,310
| +0.3% | +$978K | 0.05% | 273 |
|
|
2021
Q3 | $311M | Buy |
2,589,583
+107,212
| +4% | +$12.5M | 0.05% | 260 |
|
|
2021
Q2 | $297M | Buy |
2,482,371
+158,972
| +7% | +$17.4M | 0.05% | 265 |
|
|
2021
Q1 | $231M | Buy |
2,323,399
+8,525
| +0.4% | +$857K | 0.04% | 281 |
|
|
2020
Q4 | $231M | Sell |
2,314,874
-443,916
| -16% | -$47M | 0.04% | 268 |
|
|
2020
Q3 | $302M | Buy |
2,758,790
+3,836
| +0.1% | +$427K | 0.07% | 235 |
|
|
2020
Q2 | $291M | Buy |
2,754,954
+13,336
| +0.5% | +$1.38M | 0.07% | 217 |
|
|
2020
Q1 | $245M | Buy |
2,741,618
+771,833
| +39% | +$72.7M | 0.07% | 211 |
|
|
2019
Q4 | $196M | Sell |
1,969,785
-2,937,825
| -60% | -$277M | 0.04% | 259 |
|
|
2019
Q3 | $437M | Buy |
4,907,610
+272,480
| +6% | +$23.6M | 0.11% | 178 |
|
|
2019
Q2 | $383M | Buy |
4,635,130
+397,619
| +9% | +$31.2M | 0.09% | 187 |
|
|
2019
Q1 | $343M | Buy |
4,237,511
+1,237,499
| +41% | +$97.5M | 0.08% | 196 |
|
|
2018
Q4 | $228M | Sell |
3,000,012
-503,264
| -14% | -$39.3M | 0.06% | 217 |
|
|
2018
Q3 | $277M | Buy |
3,503,276
+4
| +0% | +$303 | 0.07% | 215 |
|
|
2018
Q2 | $246M | Hold |
3,503,272
| – | – | 0.05% | 225 |
|
|
2018
Q1 | $245M | Buy |
3,503,272
+1,263,980
| +56% | +$87.6M | 0.06% | 225 |
|
|
2017
Q4 | $155M | Buy |
2,239,292
+2
| +0% | +$135 | 0.03% | 258 |
|
|
2017
Q3 | $152M | Buy |
2,239,290
+2,009,287
| +874% | +$127M | 0.03% | 255 |
|
|
2017
Q2 | $15.7M | Buy |
230,003
+3
| +0% | +$196 | ﹤0.01% | 440 |
|
|
2017
Q1 | $14.3M | Hold |
230,000
| – | – | ﹤0.01% | 441 |
|
|
2016
Q4 | $12.6M | Hold |
230,000
| – | – | ﹤0.01% | 437 |
|
|
2016
Q3 | $15.1M | Hold |
230,000
| – | – | ﹤0.01% | 421 |
|
|
2016
Q2 | $13.9M | Sell |
230,000
-1,145,000
| -83% | -$66.5M | ﹤0.01% | 420 |
|
|
2016
Q1 | $77.4M | Buy |
1,375,000
+445,000
| +48% | +$26.7M | 0.02% | 300 |
|
|
2015
Q4 | $63.1M | Buy |
930,000
+700,000
| +304% | +$45.9M | 0.02% | 321 |
|
|
2015
Q3 | $14.6M | Hold |
230,000
| – | – | ﹤0.01% | 451 |
|
|
2015
Q2 | $14.7M | Hold |
230,000
| – | – | ﹤0.01% | 470 |
|
|
2015
Q1 | $15.7M | Hold |
230,000
| – | – | ﹤0.01% | 461 |
|
|
2014
Q4 | $16.2M | Sell |
230,000
-80,000
| -26% | -$5.73M | ﹤0.01% | 455 |
|
|
2014
Q3 | $22.1M | Hold |
310,000
| – | – | 0.01% | 423 |
|
|
2014
Q2 | $23M | Sell |
310,000
-700,000
| -69% | -$50.6M | 0.01% | 416 |
|
|
2014
Q1 | $65.5M | Sell |
1,010,000
-660,000
| -40% | -$42.6M | 0.02% | 331 |
|
|
2013
Q4 | $99.1M | Hold |
1,670,000
| – | – | 0.03% | 297 |
|
|
2013
Q3 | $86.7M | Hold |
1,670,000
| – | – | 0.03% | 305 |
|
|
2013
Q2 | $79M | Buy |
+1,670,000
| New | +$85M | 0.03% | 306 |
|
Other funds holding AZN
EPGL
VCM
VAM
VFT
Capital World Investors's AZN Position: Q2 2026 in Review
Capital World Investors increased its AstraZeneca (AZN) stake by 6.4% in Q2 2026, buying an estimated $341M and bringing the position to 30,075,134 shares worth $5.63B. The position accounts for 0.67% of the portfolio, ranked #38.
Capital World Investors first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,259 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Capital World Investors held 30,075,134 shares of AstraZeneca worth $5.63B as of Q2 2026.
- Capital World Investors bought 1,810,554 AstraZeneca shares in Q2 2026, an estimated $341M.
- AstraZeneca made up 0.67% of Capital World Investors's portfolio in Q2 2026, its #38 holding.
- Capital World Investors first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 1,259 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.